These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 21994070
41. Altered Cortico-Limbic Network Connectivity in Parkinsonian Depression: The Effect of Antidepressants. Morgan HE, Ledbetter CR, Ferrier C, Zweig RM, Disbrow EA. J Parkinsons Dis; 2018; 8(3):429-440. PubMed ID: 30124452 [Abstract] [Full Text] [Related]
42. Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Merlet I, Ryvlin P, Costes N, Dufournel D, Isnard J, Faillenot I, Ostrowsky K, Lavenne F, Le Bars D, Mauguière F. Neuroimage; 2004 Jun; 22(2):886-96. PubMed ID: 15193619 [Abstract] [Full Text] [Related]
43. Molecular Imaging of the Serotonergic System in Parkinson's Disease. Pagano G, Politis M. Int Rev Neurobiol; 2018 Jun; 141():173-210. PubMed ID: 30314596 [Abstract] [Full Text] [Related]
44. Acute physical stress induces the alteration of the serotonin 1A receptor density in the hippocampus. Choi JY, Shin S, Lee M, Jeon TJ, Seo Y, Kim CH, Kim DG, Yi CH, Lee K, Choi TH, Kang JH, Ryu YH. Synapse; 2014 Aug; 68(8):363-8. PubMed ID: 24771590 [Abstract] [Full Text] [Related]
45. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ. Mol Psychiatry; 2004 Apr; 9(4):386-92. PubMed ID: 15042104 [Abstract] [Full Text] [Related]
49. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET. Hansen AK, Knudsen K, Lillethorup TP, Landau AM, Parbo P, Fedorova T, Audrain H, Bender D, Østergaard K, Brooks DJ, Borghammer P. Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023 [Abstract] [Full Text] [Related]
50. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. Wile DJ, Agarwal PA, Schulzer M, Mak E, Dinelle K, Shahinfard E, Vafai N, Hasegawa K, Zhang J, McKenzie J, Neilson N, Strongosky A, Uitti RJ, Guttman M, Zabetian CP, Ding YS, Adam M, Aasly J, Wszolek ZK, Farrer M, Sossi V, Stoessl AJ. Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296 [Abstract] [Full Text] [Related]
53. Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women. Moser U, Wadsak W, Spindelegger C, Mitterhauser M, Mien LK, Bieglmayer C, Kletter K, Kasper S, Lanzenberger R. Neurosci Lett; 2010 Jun 07; 476(3):161-5. PubMed ID: 20399839 [Abstract] [Full Text] [Related]
54. Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals. Vidal B, Sebti J, Verdurand M, Fieux S, Billard T, Streichenberger N, Troakes C, Newman-Tancredi A, Zimmer L. Neuropharmacology; 2016 Oct 07; 109():88-95. PubMed ID: 27183968 [Abstract] [Full Text] [Related]
56. Hippocampal 5-HT1A receptor binding is related to object-location memory in humans. Glikmann-Johnston Y, Saling MM, Chen J, O'Keefe G, Gong S, Tochon-Danguy H, Mulligan R, Reutens DC. Brain Struct Funct; 2015 Jan 07; 220(1):559-70. PubMed ID: 24807817 [Abstract] [Full Text] [Related]
57. 5-HT(1A) receptor binding changes in patients with major depressive disorder before and after antidepressant treatment: a pilot [¹⁸F]MPPF positron emission tomography study. Lothe A, Saoud M, Bouvard S, Redouté J, Lerond J, Ryvlin P. Psychiatry Res; 2012 Jul 30; 203(1):103-4. PubMed ID: 22863653 [Abstract] [Full Text] [Related]